Stephen Salloway
Impact in
- Psychiatry and Mental health top 0.1%
- Dementia and Cognitive Impairment Research
- Neurology top 0.1%
- Neurological disorders and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Dementia and Cognitive Impairment Research 64
- Physiology 64
- Alzheimer's disease research and treatments 62
- Co-authors
- Kaj Blennow (9 shared papers)Bart De Strooper (2 shared papers)Giovanni B. Frisoni (2 shared papers)Philip Scheltens (2 shared papers)Wiesje M. van der Flier (2 shared papers)Monique M.B. Breteler (1 shared paper)Paul Malloy (26 shared papers)Jeffrey L. Cummings (21 shared papers)
- Journals
- Alzheimer s & Dementia (48 papers)The Journal of Prevention of Alzheimer s Disease (11 papers)Neurology (11 papers)Journal of Neuropsychiatry (9 papers)Alzheimer s Research & Therapy (7 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Stephen Salloway
181 papers receiving 14.6k citations
Stephen Salloway's Hit Papers
Peers
Comparison fields: 5 of 159
- Psychiatry and Mental health 4.3k
- Neurology 2.3k
- Biological Psychiatry 540
- Physiology 4.8k
- Neurology 2.5k
Countries citing papers authored by Stephen Salloway
This map shows the geographic impact of Stephen Salloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Salloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Salloway more than expected).
Fields of papers citing papers by Stephen Salloway
This network shows the impact of papers produced by Stephen Salloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Salloway. The network helps show where Stephen Salloway may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Salloway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Alzheimer's disease Hit paper breakdown → | 2016 | 2533 |
| 2 | Donanemab in Early Alzheimer’s Disease Hit paper breakdown → | 2021 | 1060 |
| 3 | Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression Hit paper breakdown → | 2008 | 701 |
| 4 | Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group Hit paper breakdown → | 2021 | 657 |
| 5 | Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience Hit paper breakdown → | 2008 | 620 |
| 6 | Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder Hit paper breakdown → | 2006 | 606 |
| 7 | Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease Hit paper breakdown → | 2021 | 437 |
| 8 | 2010 | 397 | |
| 9 | Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis Hit paper breakdown → | 2012 | 388 |
| 10 | The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease Hit paper breakdown → | 2022 | 335 |
| 11 | 2003 | 283 | |
| 12 | 2010 | 282 | |
| 13 | 2017 | 273 | |
| 14 | 2000 | 267 | |
| 15 | 2004 | 246 | |
| 16 | 1996 | 241 | |
| 17 | 2003 | 240 | |
| 18 | 2011 | 219 | |
| 19 | Aducanumab: Appropriate Use Recommendations Hit paper breakdown → | 2021 | 215 |
| 20 | 2008 | 198 |
About Stephen Salloway
Stephen Salloway is a scholar working on Psychiatry and Mental health, Physiology, Neurology, Pharmacology and Cognitive Neuroscience, having authored 189 papers that have together received 15.1k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (64 papers), Alzheimer's disease research and treatments (62 papers), Cholinesterase and Neurodegenerative Diseases (19 papers), Neurological disorders and treatments (10 papers), Functional Brain Connectivity Studies (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers) and Obsessive-Compulsive Spectrum Disorders (5 papers). The work is most often cited by research in Psychiatry and Mental health (4.3k citations), Neurology (2.3k citations), Biological Psychiatry (540 citations), Physiology (4.8k citations) and Neurology (2.5k citations). Stephen Salloway has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Kaj Blennow, Bart De Strooper, Giovanni B. Frisoni, Philip Scheltens, Wiesje M. van der Flier, Monique M.B. Breteler, Paul Malloy, Jeffrey L. Cummings, Reisa A. Sperling and Steven A. Rasmussen. Their work appears in journals such as Alzheimer s & Dementia, The Journal of Prevention of Alzheimer s Disease, Neurology, Journal of Neuropsychiatry and Alzheimer s Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.